ArticleGut2024
Identification of PRMT5 as a therapeutic target in cholangiocarcinoma.
Jasmin Elurbide et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it
ArticleGut2024
Jasmin Elurbide et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.